OLINVYK
Drug
Trevena, Inc.
Total Payments
$1.5M
Transactions
1,572
Doctors
926
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $56,401 | 50 | 41 |
| 2023 | $351,230 | 578 | 375 |
| 2022 | $955,935 | 387 | 244 |
| 2021 | $149,998 | 557 | 339 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.0M | 25 | 68.0% |
| Consulting Fee | $286,863 | 63 | 19.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $122,513 | 52 | 8.1% |
| Food and Beverage | $44,948 | 1,077 | 3.0% |
| Travel and Lodging | $25,675 | 61 | 1.7% |
| Education | $4,688 | 294 | 0.3% |
Payments by Type
Research
$1.0M
25 transactions
General
$484,687
1,547 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| TRV130 : CP130-4002 Volition Trial | Trevena, Inc. | $957,649 | 1 |
| TRV130 : CP130-4001 RWE | Trevena, Inc. | $44,604 | 0 |
| Phase 4 Respiratory Safety Study | Trevena, Inc. | $22,625 | 1 |
| Pediatric study | Trevena, Inc. | $4,000 | 1 |
Top Doctors Receiving Payments for OLINVYK
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Winston Salem, NC | $992,953 | 18 |
| , MD | Internal Medicine | Skillman, NJ | $181,650 | 26 |
| , M.D | Specialist | Covington, GA | $58,121 | 52 |
| , M.D | Anesthesiology | Cleveland, OH | $38,809 | 13 |
| , M.D, | Specialist | Bend, OR | $27,869 | 16 |
| , MD | Surgery | Mobile, AL | $25,300 | 47 |
| , MD | Anesthesiology | Mechanicsburg, PA | $17,872 | 17 |
| , M.D | Critical Care Medicine | Winston Salem, NC | $14,299 | 6 |
| , MD | Anesthesiology | Cleveland, OH | $12,916 | 5 |
| , MD | Anesthesiology | Columbus, OH | $10,434 | 12 |
| , M.D | Anesthesiology | Rochester, MN | $9,300 | 1 |
| , MD | Pain Medicine | Winston Salem, NC | $8,468 | 16 |
| , MD | Anesthesiology | Louisville, KY | $7,570 | 9 |
| , MD | Neurology | Birmingham, AL | $6,431 | 3 |
| , MD | Anesthesiology | Philadelphia, PA | $6,000 | 1 |
| , MD | Neurology with Special Qualifications in Child Neurology | Boston, MA | $4,981 | 2 |
| , DO | Anesthesiology | Rockford, IL | $4,751 | 11 |
| Govind Rangrass | Anesthesiology | Saint Louis, MO | $4,197 | 4 |
| , M.D | Critical Care Medicine | Atlanta, GA | $4,070 | 2 |
| , M.D | Surgical Critical Care | Sacramento, CA | $4,053 | 4 |
| , M.D | Anesthesiology | Stanford, CA | $4,024 | 2 |
| , M.D | Psychiatry | Malvern, PA | $3,600 | 1 |
| , M.D | Anesthesiology | Houston, TX | $3,500 | 1 |
| , MD, PHD | Neurology | Nashville, TN | $3,475 | 1 |
| , M.D | Surgery | Weston, FL | $2,500 | 1 |
Ad
Manufacturing Companies
- Trevena, Inc. $1.5M
Product Information
- Type Drug
- Total Payments $1.5M
- Total Doctors 926
- Transactions 1,572
About OLINVYK
OLINVYK is a drug associated with $1.5M in payments to 926 healthcare providers, recorded across 1,572 transactions in the CMS Open Payments database. The primary manufacturer is Trevena, Inc..
Payment data is available from 2021 to 2024. In 2024, $56,401 was paid across 50 transactions to 41 doctors.
The most common payment nature for OLINVYK is "Unspecified" ($1.0M, 68.0% of total).
OLINVYK is associated with 4 research studies, including "TRV130 : CP130-4002 Volition Trial" ($957,649).